Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$324.3 - $354.67 $1.45 Million - $1.58 Million
4,467 Added 130.12%
7,900 $2.69 Million
Q1 2024

May 15, 2024

BUY
$293.94 - $358.71 $1.01 Million - $1.23 Million
3,433 New
3,433 $1.23 Million
Q3 2023

Nov 14, 2023

SELL
$266.54 - $302.43 $2.59 Million - $2.93 Million
-9,700 Reduced 82.91%
2,000 $546,000
Q2 2023

Aug 14, 2023

BUY
$271.49 - $305.09 $3.18 Million - $3.57 Million
11,700 New
11,700 $3.57 Million
Q4 2022

Feb 14, 2023

SELL
$205.51 - $253.93 $2.38 Million - $2.95 Million
-11,600 Reduced 87.22%
1,700 $415,000
Q3 2022

Nov 14, 2022

BUY
$189.27 - $231.83 $302,832 - $370,928
1,600 Added 13.68%
13,300 $2.69 Million
Q2 2022

Aug 15, 2022

BUY
$194.09 - $276.37 $2.27 Million - $3.23 Million
11,700 New
11,700 $2.33 Million
Q3 2021

Nov 15, 2021

SELL
$248.9 - $280.09 $3.16 Million - $3.56 Million
-12,700 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$242.95 - $267.0 $437,310 - $480,600
-1,800 Reduced 12.41%
12,700 $3.3 Million
Q1 2021

May 17, 2021

BUY
$221.01 - $248.82 $3.2 Million - $3.61 Million
14,500 New
14,500 $3.53 Million
Q3 2020

Nov 16, 2020

SELL
$177.77 - $215.81 $71,108 - $86,324
-400 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$144.67 - $207.03 $57,867 - $82,812
400 New
400 $72,000
Q2 2019

Aug 14, 2019

SELL
$180.24 - $205.58 $5.7 Million - $6.5 Million
-31,600 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$152.46 - $198.0 $3.17 Million - $4.12 Million
20,800 Added 192.59%
31,600 $6.24 Million
Q3 2018

Nov 14, 2018

BUY
$163.25 - $177.68 $1.76 Million - $1.92 Million
10,800 New
10,800 $1.92 Million
Q2 2018

Aug 14, 2018

SELL
$155.17 - $179.78 $434,475 - $503,384
-2,800 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$148.01 - $168.91 $414,428 - $472,948
2,800 New
2,800 $451,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $146B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.